JPRN-UMIN000005133已完成未知
Continuous administration trial of PEGASUS-PC Study (Phase2/3 study of OTS102 in Combination With Gemcitabine in Patients With Unresectable Advanced Pancreatic Cancer and Recurrent Pancreatic Cancer) - Continuous administration trial of PEGASUS-PC Study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 7
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Nothing particular
研究者
相似试验
未知
4 期
Post-marketing clinical trial of Pegasys 180ug for subcutaneous injection (s.c.) in patients with chronic hepatitis C. -General clinical study in IFN-treated or IFN-untreated chronic hepatitis C patients, except for those infected with genotype 1b of hepatitis C virus and a high viral load.Chronic hepatitis CJPRN-jRCT1080220157Chugai Pharmaceutical Co., Ltd.
已完成
不适用
Continuous administration trial of Phase2 Study of OCV-101 in Combination With Gemcitabine in Patients With Unresectable Advanced Pancreatic Cancer and Recurrent Pancreatic Cancernresectable Advanced and Recurrent Pancreatic cancerJPRN-UMIN000009085OncoTherapy Science, Inc.2
已完成
不适用
Continuous administration trial of Phase2 Study of OTS102 in Combination With Gemcitabine in Patients With Unresectable Advanced Biliary Tract Cancer and recurrent Biliary Tract Cancernresectable Advanced and Recurrent Biliary Tract CancerJPRN-UMIN000006436OncoTherapy Science, Inc.7
进行中（未招募）
1 期
GaPP: comparing gabapentin and placebo for Pelvic PaiEUCTR2011-005494-22-GBniversity of Edinburgh47
进行中（未招募）
不适用
A randomised controlled trial of efficacy of Pegaptanib sodium in the prevention of proliferative diabetic retinopathy - EPPPDRMedDRA version: 9.1Level: LLTClassification code 10054109Term: Non-proliferative diabetic retinopathyDiabetic RetinopathyEUCTR2007-006795-10-GBFrimley Park Hospital NHS Foundation Trust